![Ronald DePinho](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ronald DePinho
Fondateur chez
Asylia Therapeutics, Inc.
Fortune : 767 142 $ au 31/08/2026
Profil
Ronald A. DePinho was the founder of Karyopharm Therapeutics, Inc. founded in 2008, serving as Director from 2009 to 2012.
Dr. DePinho was the founder of Metamark Genetics, Inc. founded in 2007, serving as Director.
Dr. DePinho was the founder of Dana-Farber Cancer Institute, Inc. founded in 1998, serving as Member from 1998 to 2009.
Dr. DePinho was the founder of AVEO Pharmaceuticals, Inc. founded in 2001, serving as Director from 2010 to 2012.
Dr. DePinho was the founder of Tvardi Therapeutics, Inc. (Old) founded in 2017, serving as Chairman.
Dr. DePinho is the founder of Asylia Therapeutics, Inc. founded in 2019, serving as Co-Chairman since 2019.
Dr. DePinho is also the founder of Nirogy Therapeutics, Inc.,Sporos Bioventures LLC,Stellanova Therapeutics, Inc...
Dr. DePinho is Chairman of The NCI Mouse Models of Human Cancers Consortium.
Dr. DePinho is Director of Greater Houston Partnership Inc. Dr. DePinho is Director of BioHouston, Inc. Dr. DePinho is Member of National Cancer Institute.
Dr. DePinho is Member of American Academy of Arts & Sciences.
Dr. DePinho is Member of National Academy of Medicine (United States).
Former positions include Director at American Association for Cancer Research.
Former Director at Technology & Entrepreneurship Center of Houston.
President of The University of Texas M.D.
Anderson Cancer Center from 2011 to 2017.
Member-Medical Oncology & Medicine Department at Harvard Medical School from 1998 to 2009.
Education includes undergraduate degree from Fordham University and doctorate from Albert Einstein College of Medicine, Inc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
3,2% | 31/12/2025 | 426 190 ( 3,2% ) | 767 142 $ | 31/08/2026 |
Postes actifs de Ronald DePinho
| Sociétés | Poste | Début |
|---|---|---|
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Corporate Officer/Principal | - |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Corporate Officer/Principal | 21/12/2009 |
THe NCI Mouse Models of Human Cancers Consortium
 THe NCI Mouse Models of Human Cancers Consortium General GovernmentGovernment Provides healthcare services | Président | 23/06/2011 |
American Academy of Arts & Sciences
 American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Corporate Officer/Principal | - |
Greater Houston Partnership Inc
 Greater Houston Partnership Inc Investment Trusts/Mutual FundsMiscellaneous Greater Houston Partnership operates as a place for community-minded business leaders who want to be involved in Houston''s positive growth and influence the direction. The company was founded in 1840 and is headquartered in Houston, TX. | Directeur/Membre du Conseil | - |
BioHouston, Inc.
 BioHouston, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in life science and biotechnology commercialization | Directeur/Membre du Conseil | - |
Asylia Therapeutics, Inc.
 Asylia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for the immune diseases | Fondateur | 01/01/2019 |
Anciens postes connus de Ronald DePinho
| Sociétés | Poste | Fin |
|---|---|---|
The University of Texas M.D. Anderson Cancer Center
 The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services Provides cancer patient care, research and prevention for cancer | Directeur Général | - |
| AVEO PHARMACEUTICALS, INC. | Fondateur | 31/12/2012 |
| ░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
| ░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
Formation de Ronald DePinho
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
61
Relations au 1er degré
21
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 21 |
|---|---|
Metamark Genetics, Inc.
 Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Provides molecular diagnostics services | Health Services |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Health Services |
Fordham University
 Fordham University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
The University of Texas M.D. Anderson Cancer Center
The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services Provides cancer patient care, research and prevention for cancer | Consumer Services |
Greater Houston Partnership Inc
Greater Houston Partnership Inc Investment Trusts/Mutual FundsMiscellaneous Greater Houston Partnership operates as a place for community-minded business leaders who want to be involved in Houston''s positive growth and influence the direction. The company was founded in 1840 and is headquartered in Houston, TX. | Miscellaneous |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Commercial Services |
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Commercial Services |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Commercial Services |
BioHouston, Inc.
BioHouston, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in life science and biotechnology commercialization | Commercial Services |
Technology & Entrepreneurship Center of Houston
 Technology & Entrepreneurship Center of Houston Investment ManagersFinance Provides investment advisory and consulting services to entrepreneurs | Finance |
Albert Einstein College of Medicine, Inc.
 Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
THe NCI Mouse Models of Human Cancers Consortium
THe NCI Mouse Models of Human Cancers Consortium General GovernmentGovernment Provides healthcare services | Government |
Tvardi Therapeutics, Inc.
 Tvardi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel and oral molecule therapies for STAT3 to treat fibrosis-driven diseases | Health Technology |
Asylia Therapeutics, Inc.
Asylia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for the immune diseases | Health Technology |
Nirogy Therapeutics, Inc.
 Nirogy Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Sporos Bioventures, Inc.
 Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Stellanova Therapeutics, Inc.
 Stellanova Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapies targeting cancer-?associated fibroblasts and their symbiotic interactions within the tumor microenvironment | Health Technology |
